Terms: = Pancreatic cancer AND PRF1, P14222, PFP, P1, MGC65093, HPLH2, FLH2, ENSG00000180644, 5551 AND Treatment
31 results:
1. A prospective phase II study of biweekly S-1, leucovorin, and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma - The Taiwan Cooperative Oncology Group T1217 study.
Bai LY; Li CP; Shan YS; Chuang SC; Chen JS; Chiang NJ; Chen YY; Tsou HH; Chuang MH; Chiu CF; Liu TW; Chen LT
Eur J Cancer; 2022 Sep; 173():123-132. PubMed ID: 35932625
[TBL] [Abstract] [Full Text] [Related]
2. Wilms Tumor 1-Associated Protein Expression Is Linked to a T-Cell-Inflamed Phenotype in pancreatic cancer.
Xu JL
Dig Dis Sci; 2023 Mar; 68(3):831-840. PubMed ID: 35859262
[TBL] [Abstract] [Full Text] [Related]
3. Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial.
Krug S; Kegel T; Gress TM; Rinke A; Apostolidis L; Jann H; König A; Hörsch D; Schrader J; Ettrich TJ; Richter M; Steighardt J; Michl P
BMC Cancer; 2021 Nov; 21(1):1206. PubMed ID: 34772353
[TBL] [Abstract] [Full Text] [Related]
4. Oncolytic Adenovirus Coding for a Variant Interleukin 2 (vIL-2) Cytokine Re-Programs the Tumor Microenvironment and Confers Enhanced Tumor Control.
Quixabeira DCA; Zafar S; Santos JM; Cervera-Carrascon V; Havunen R; Kudling TV; Basnet S; Anttila M; Kanerva A; Hemminki A
Front Immunol; 2021; 12():674400. PubMed ID: 34084172
[TBL] [Abstract] [Full Text] [Related]
5. One-step modification to identify dual-inhibitors targeting both pancreatic triglyceride lipase and Niemann-Pick C1-like 1.
Zhang R; Song Z; Wang X; Xue J; Xing D
Eur J Med Chem; 2021 Apr; 216():113358. PubMed ID: 33725656
[TBL] [Abstract] [Full Text] [Related]
6. Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients.
Mattiucci GC; Boldrini L; Nardangeli A; D'Aviero A; Buwenge M; Cellini F; Deodato F; Dinapoli N; Frascino V; Macchia G; Morganti AG; Valentini V
J Cancer Res Clin Oncol; 2021 Mar; 147(3):661-667. PubMed ID: 33001271
[TBL] [Abstract] [Full Text] [Related]
7. Multicentre observational cohort study of implementation and outcomes of laparoscopic distal pancreatectomy.
Lof S; Moekotte AL; Al-Sarireh B; Ammori B; Aroori S; Durkin D; Fusai GK; French JJ; Gomez D; Marangoni G; Marudanayagam R; Soonawalla Z; Sutcliffe R; White SA; Abu Hilal M;
Br J Surg; 2019 Nov; 106(12):1657-1665. PubMed ID: 31454072
[TBL] [Abstract] [Full Text] [Related]
8. A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic pancreatic Adenocarcinoma: North Central cancer treatment Group Trial N064B (Alliance).
Halfdanarson TR; Foster NR; Kim GP; Meyers JP; Smyrk TC; McCullough AE; Ames MM; Jaffe JP; Alberts SR
Oncologist; 2019 May; 24(5):589-e160. PubMed ID: 30679315
[TBL] [Abstract] [Full Text] [Related]
9. Zinc(II) Metalated Porphyrins as Photothermogenic Photosensitizers for cancer Photodynamic/Photothermal Synergistic Therapy.
Ding K; Zhang Y; Si W; Zhong X; Cai Y; Zou J; Shao J; Yang Z; Dong X
ACS Appl Mater Interfaces; 2018 Jan; 10(1):238-247. PubMed ID: 29243919
[TBL] [Abstract] [Full Text] [Related]
10. Incidence, diagnostic, treatment and outcome of patients diagnosed with cancer of the pancreas during 1986-2009: a population-based study.
Jonsdottir SB; Juliusson G; Kristinsson JÖ; Hreinsson JP; Jonasson JG; Björnsson ES
Scand J Gastroenterol; 2018 Jan; 53(1):100-106. PubMed ID: 29058490
[TBL] [Abstract] [Full Text] [Related]
11. Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.
Ishigami H; Yamaguchi H; Yamashita H; Asakage M; Kitayama J
Gastric Cancer; 2017 Mar; 20(Suppl 1):128-134. PubMed ID: 28028665
[TBL] [Abstract] [Full Text] [Related]
12. [Intraperitoneal Chemotherapy for Peritoneal Metastasis of Gastric cancer].
Yamaguchi H; Ishigami H; Kitayama J
Gan To Kagaku Ryoho; 2016 Dec; 43(13):2481-2485. PubMed ID: 28028253
[TBL] [Abstract] [Full Text] [Related]
13. Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in pancreatic Ductal Adenocarcinoma.
Connor AA; Denroche RE; Jang GH; Timms L; Kalimuthu SN; Selander I; McPherson T; Wilson GW; Chan-Seng-Yue MA; Borozan I; Ferretti V; Grant RC; Lungu IM; Costello E; Greenhalf W; Palmer D; Ghaneh P; Neoptolemos JP; Buchler M; Petersen G; Thayer S; Hollingsworth MA; Sherker A; Durocher D; Dhani N; Hedley D; Serra S; Pollett A; Roehrl MHA; Bavi P; Bartlett JMS; Cleary S; Wilson JM; Alexandrov LB; Moore M; Wouters BG; McPherson JD; Notta F; Stein LD; Gallinger S
JAMA Oncol; 2017 Jun; 3(6):774-783. PubMed ID: 27768182
[TBL] [Abstract] [Full Text] [Related]
14. 18F-fluoro-2-deoxy-D-glucose retention index as a prognostic parameter in patients with pancreatic cancer.
Xi Y; Guo R; Hu J; Zhang M; Zhang X; Li B
Nucl Med Commun; 2014 Nov; 35(11):1112-8. PubMed ID: 25098308
[TBL] [Abstract] [Full Text] [Related]
15. A phase I clinical trial of vaccination with KIF20A-derived peptide in combination with gemcitabine for patients with advanced pancreatic cancer.
Suzuki N; Hazama S; Ueno T; Matsui H; Shindo Y; Iida M; Yoshimura K; Yoshino S; Takeda K; Oka M
J Immunother; 2014 Jan; 37(1):36-42. PubMed ID: 24316554
[TBL] [Abstract] [Full Text] [Related]
16. First-line erlotinib and fixed dose-rate gemcitabine for advanced pancreatic cancer.
Vaccaro V; Bria E; Sperduti I; Gelibter A; Moscetti L; Mansueto G; Ruggeri EM; Gamucci T; Cognetti F; Milella M
World J Gastroenterol; 2013 Jul; 19(28):4511-9. PubMed ID: 23901226
[TBL] [Abstract] [Full Text] [Related]
17. Insulin-like growth factor I receptor involvement in proliferation of NOR-P1 cells in serum-free media.
Tomizawa M; Shinozaki F; Sugiyama T; Yamamoto S; Sueishi M; Yoshida T
J Cell Biochem; 2012 Aug; 113(8):2714-20. PubMed ID: 22441995
[TBL] [Abstract] [Full Text] [Related]
18. Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine followed by chemoradiation in pancreatic cancer: a randomized phase II trial.
Reni M; Balzano G; Aprile G; Cereda S; Passoni P; Zerbi A; Tronconi MC; Milandri C; Saletti P; Rognone A; Fugazza C; Magli A; Di Muzio N; Di Carlo V; Villa E
Ann Surg Oncol; 2012 Jul; 19(7):2256-63. PubMed ID: 22237835
[TBL] [Abstract] [Full Text] [Related]
19. Salvage therapy with mitomycin and ifosfamide in patients with gemcitabine-resistant metastatic pancreatic cancer: a phase II trial.
Cereda S; Reni M; Rognone A; Fugazza C; Ghidini M; Ceraulo D; Brioschi M; Nicoletti R; Villa E
Chemotherapy; 2011; 57(2):156-61. PubMed ID: 21454973
[TBL] [Abstract] [Full Text] [Related]
20. Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung.
Kalinina T; Güngör C; Thieltges S; Möller-Krull M; Penas EM; Wicklein D; Streichert T; Schumacher U; Kalinin V; Simon R; Otto B; Dierlamm J; Schwarzenbach H; Effenberger KE; Bockhorn M; Izbicki JR; Yekebas EF
BMC Cancer; 2010 Jun; 10():295. PubMed ID: 20553613
[TBL] [Abstract] [Full Text] [Related]
[Next]
